Psychedelics Today, Author at PsyNews.com

Home Authors Posts by Watertime

256 POSTS 0 COMMENTS

Ibogaine – The Promise, the Protocol, and Protecting the Sacred

Pα+ Psychedelic Bulletin #195: Psychedelics Namechecked in Trump Cabinet Meeting; Noma...

“Neuropharmacology: Psychedelics on the Brain” – Jim Harris, Rachel Zoeller, DPT, David...

March & April 2025 Psychedelic Patent Update: Lykos’ Patent Woes Continue;...

Dispatch from Breaking Convention 2025: Insights from Europe’s Largest Psychedelic Research...

Understanding Our Roots and Respecting Indigenous Wisdom

Pα+ Psychedelic Bulletin #194: Make-or-Break Moment Looms for Compass; RFK Jr....

Diane Goldstein, Sarko Gergerian and Rick Doblin

Psychedelic Science 2025: A Convergence of Data, Discovery, and Integration

Zach Leary – Your Extraordinary Mind

1...8910...26 Page 9 of 26

EDITOR PICKS

From Huxley to Heffter: Mark Geyer Reflects on a Life in...

Advanced Shadow Work and Psychedelic Integration: A Jungian Path to Wholeness

Essentials of Psychedelic Therapy & Integration

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Watertime